| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0092-8674(88)90154-7 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0092867488901547?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:0092867488901547?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 3365766 |
| P2093 | author name string | L. R. Gooding | |
| W. S. Wold | |||
| L. W. Elmore | |||
| A. E. Tollefson | |||
| H. A. Brady | |||
| P2860 | cites work | Tumor necrosis factor (TNF). | Q34378376 |
| Identification of a novel sequence that governs both polyadenylation and alternative splicing in region E3 of adenovirus | Q34723405 | ||
| Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon | Q36351193 | ||
| Identification and gene mapping of a 14,700-molecular-weight protein encoded by region E3 of group C adenoviruses | Q36825617 | ||
| An adenovirus mRNA which encodes a 14,700-Mr protein that maps to the last open reading frame of region E3 is expressed during infection | Q36866459 | ||
| Nuclear envelope localization of an adenovirus tumor antigen maintains the integrity of cellular DNA | Q36955675 | ||
| Expression of the adenovirus E1A oncogene during cell transformation is sufficient to induce susceptibility to lysis by host inflammatory cells | Q37399643 | ||
| Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line | Q37595128 | ||
| Specificities of killing by T lymphocytes generated against syngeneic SV40 transformants: studies employing recombinants within the H-2 complex | Q39548532 | ||
| The role of cachectin/TNF in endotoxic shock and cachexia | Q39580667 | ||
| 36 Human adenoviruses: Growth, purification, and transfection assay | Q41460017 | ||
| Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF. | Q42805963 | ||
| Antiviral effects of recombinant tumour necrosis factor in vitro | Q44422722 | ||
| Deletion mutants of adenovirus 2: Isolation and initial characterization of virus carrying mutations near the right end of the viral genome | Q45791814 | ||
| Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons | Q45848193 | ||
| Region E3 of human adenoviruses; differences between the oncogenic adenovirus-3 and the non-oncogenic adenovirus-2. | Q48370075 | ||
| A short sequence in the COOH-terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum | Q64379750 | ||
| Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance | Q64380296 | ||
| An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens | Q64380351 | ||
| Synthesis and genomic site for an adenovirus type 2 early glycoprotein | Q64381895 | ||
| Isolation of deletion and substitution mutants of adenovirus type 5 | Q64382239 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | 341-346 | |
| P577 | publication date | 1988-05-01 | |
| 1988-05-06 | |||
| P1433 | published in | Cell | Q655814 |
| P1476 | title | A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor | |
| P478 | volume | 53 |
| Q36801107 | A 10,400-molecular-weight membrane protein is coded by region E3 of adenovirus |
| Q37412249 | A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia |
| Q34970601 | A new generation of HIV vaccines |
| Q44303896 | A novel attenuated replication-competent adenovirus for melanoma therapy |
| Q36802357 | A protein serologically and functionally related to the group C E3 14,700-kilodalton protein is found in multiple adenovirus serotypes |
| Q39875480 | A single gene encoding the fiber is responsible for variations in virulence in the fowl adenoviruses. |
| Q45877985 | ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis |
| Q40392107 | Accumulation of p53 in response to adenovirus early region 1A sensitizes human cells to tumor necrosis factor alpha-induced apoptosis |
| Q34895124 | Adenoviral inhibitors of apoptotic cell death |
| Q64381889 | Adenoviral inhibitors of the apoptotic cascade |
| Q35889174 | Adenovirus E3 14.7-kilodalton protein, an antagonist of tumor necrosis factor cytolysis, increases the virulence of vaccinia virus in severe combined immunodeficient mice |
| Q36689099 | Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis |
| Q37395016 | Adenovirus E3 protein modulates leukocyte functions |
| Q35880562 | Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes |
| Q34330584 | Adenovirus E3-6.7K maintains calcium homeostasis and prevents apoptosis and arachidonic acid release |
| Q37596949 | Adenovirus E3-6.7K protein is required in conjunction with the E3-RID protein complex for the internalization and degradation of TRAIL receptor 2 |
| Q34356569 | Adenovirus RIDbeta subunit contains a tyrosine residue that is critical for RID-mediated receptor internalization and inhibition of Fas- and TRAIL-induced apoptosis |
| Q40463873 | Adenovirus immunoregulatory E3 proteins prolong transplants of human cells in immunocompetent mice. |
| Q38655771 | Adenovirus proteins and MHC expression. |
| Q43765820 | Adenovirus type 5 E3 gene products interfere with the expression of the cytolytic T cell immunodominant E1 a antigen |
| Q40456070 | Adenovirus-mediated gene transfer into striated muscles. |
| Q34041940 | Adenoviruses as vectors for delivering vaccines to mucosal surfaces |
| Q39877642 | Altered susceptibility to tumor necrosis factor alpha-induced apoptosis of mouse cells expressing polyomavirus middle and small T antigens. |
| Q41200381 | An Epstein-Barr virus immortalization associated gene segment interferes specifically with the IFN-induced anti-proliferative response in human B-lymphoid cell lines |
| Q40699318 | An evolutionary and functional approach to the TNF receptor/ligand family |
| Q35867799 | Analysis of early region 3 mutants of mouse adenovirus type 1 |
| Q40551607 | Apoptosis in viral infections |
| Q28472613 | Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein |
| Q37952713 | Cancer immunology: highlights of the NCI Extramural Immunology Program |
| Q30525107 | Cell-free transmission of human adenovirus by passive mass transfer in cell culture simulated in a computer model |
| Q38269484 | Characterization of Ad5 E3-14.7K, an adenoviral inhibitor of apoptosis: structure, oligomeric state, and metal binding |
| Q36686459 | Characterization of mutants within the gene for the adenovirus E3 14.7-kilodalton protein which prevents cytolysis by tumor necrosis factor. |
| Q36635189 | Characterization of transgenic mice containing adenovirus early region 3 genomic DNA |
| Q36632498 | Cytokine-mediated induction of human immunodeficiency virus (HIV) expression and cell death in chronically infected U1 cells: do tumor necrosis factor alpha and gamma interferon selectively kill HIV-infected cells? |
| Q33828633 | Cytolysis by tumor necrosis factor is preceded by a rapid and specific dissolution of microfilaments |
| Q36318182 | Development of transcriptionally regulated oncolytic adenoviruses |
| Q24653498 | Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor |
| Q41641963 | Down-regulation of E1a expression by E3 gene products in group C adenoviruses |
| Q40039400 | Down-regulation of HLA antigens by the adenovirus type 2 E3/19K protein in a T-lymphoma cell line. |
| Q90668591 | Drosophila melanogaster as a model for studying the function of animal viral proteins |
| Q36264713 | E1B 19K inhibits Fas-mediated apoptosis through FADD-dependent sequestration of FLICE. |
| Q40771367 | Elevated temperature regulates tumor necrosis factor-mediated immune killing |
| Q41043231 | Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells |
| Q35613800 | Functions and mechanisms of action of the adenovirus E3 proteins |
| Q39878719 | Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype. |
| Q39874196 | Genetic organization, size, and complete sequence of early region 3 genes of human adenovirus type 41 |
| Q54348408 | Heat shock protects WEHI-164 target cells from the cytolysis by tumor necrosis factors alpha and beta. |
| Q37844073 | Helper independent recombinant adenovirus vectors: expression of HIV env or HBV surface antigen |
| Q35873842 | Herpes simplex virus type 2 inhibition of Fas ligand expression |
| Q37254362 | Homologous recombination in E3 genes of human adenovirus species D |
| Q35662589 | Human adenovirus type 37 and the BALB/c mouse: progress toward a restricted adenovirus keratitis model (an American Ophthalmological Society thesis) |
| Q95839254 | Human mastadenovirus-B (HAdV-B)-specific E3-CR1β and E3-CR1γ glycoproteins interact with each other and localize at the plasma membrane of non-polarized airway epithelial cells |
| Q42146978 | Identification of a novel immunosubversion mechanism mediated by a virologue of the B-lymphocyte receptor TACI. |
| Q33683353 | Immune evasion by adenoviruses |
| Q33711437 | Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic. |
| Q34301871 | Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus |
| Q34055774 | Immunomodulatory functions encoded by the E3 transcription unit of adenoviruses |
| Q36782589 | Induction of sensitivity to the cytotoxic action of tumor necrosis factor alpha by adenovirus E1A is independent of transformation and transcriptional activation |
| Q35853222 | Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis |
| Q38365456 | Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism |
| Q33844897 | Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins |
| Q35000763 | Inhibition of chemokine expression by adenovirus early region three (E3) genes |
| Q24313249 | Interaction of an adenovirus 14.7-kilodalton protein inhibitor of tumor necrosis factor alpha cytolysis with a new member of the GTPase superfamily of signal transducers |
| Q24314666 | Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains |
| Q64382129 | Interaction of the adenovirus 14.7-kDa protein with FLICE inhibits Fas ligand-induced apoptosis |
| Q44702557 | Latent adenoviral infection in the pathogenesis of chronic airways obstruction |
| Q36702179 | Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus |
| Q41300792 | Molecular basis of immune evasion strategies by adenoviruses |
| Q34632063 | New hope for an AIDS vaccine |
| Q35851982 | Oncogenicity of human papillomavirus- or adenovirus-transformed cells correlates with resistance to lysis by natural killer cells. |
| Q39741495 | Promyelocytic leukemia protein isoform II inhibits infection by human adenovirus type 5 through effects on HSP70 and the interferon response. |
| Q37099438 | Region E3 of adenovirus: A cassette of genes involved in host immunosurveillance and virus-cell interactions |
| Q35841523 | Region E3 of subgroup B human adenoviruses encodes a 16-kilodalton membrane protein that may be a distant analog of the E3-6.7K protein of subgroup C adenoviruses. |
| Q36873925 | Regulation of adenovirus and cellular gene expression and of cellular transformation by the E1B-encoded 175-amino-acid protein. |
| Q24678703 | Regulation of apoptosis by viral gene products |
| Q40113141 | Replacement mutagenesis of the human cytomegalovirus genome: US10 and US11 gene products are nonessential |
| Q33741620 | Role of early genes in pathogenesis of adenovirus pneumonia |
| Q33858906 | Role of early region 3 (E3) in pathogenesis of adenovirus disease |
| Q37547013 | STAT1 interaction with E3-14.7K in monocytes affects the efficacy of oncolytic adenovirus |
| Q41678141 | Sensitivity to tumour necrosis factor-mediated cytolysis is unrelated to manganous superoxide dismutase messenger RNA levels among transformed mouse fibroblasts |
| Q36883111 | Sequence and genetic organization of adenovirus type 35 early region 3. |
| Q58764105 | Subversion of Cytokine Networks by Viruses |
| Q39984861 | Suppression of FasL expression in tumor cells and preventing TNF-induced apoptosis was better for immune cells survival |
| Q38719414 | Suppression of Type I Interferon Signaling by E1A via RuvBL1/Pontin |
| Q39878863 | Suppression of apoptotic DNA fragmentation in herpes simplex virus type 1-infected cells. |
| Q36797205 | The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor |
| Q36816831 | The 19-Kilodalton Adenovirus E1B Transforming Protein Inhibits Programmed Cell Death and Prevents Cytolysis by Tumor Necrosis Factor α |
| Q40064866 | The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells |
| Q35895541 | The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type. |
| Q39877199 | The activity of cytosolic phospholipase A2 is required for the lysis of adenovirus-infected cells by tumor necrosis factor |
| Q36692798 | The adenovirus E3 14.5-kilodalton protein, which is required for down-regulation of the epidermal growth factor receptor and prevention of tumor necrosis factor cytolysis, is an integral membrane protein oriented with its C terminus in the cytoplasm |
| Q36620321 | The adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model. |
| Q35898131 | The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis |
| Q35865485 | The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid |
| Q40376990 | The adenovirus E3-6.7K protein adopts diverse membrane topologies following posttranslational translocation |
| Q35858778 | The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells |
| Q36681830 | The amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cells |
| Q36832475 | The mouse adenovirus type 1 contains an unusual E3 region |
| Q40605944 | The origins of the small DNA tumor viruses |
| Q33599759 | The regulation of apoptosis by microbial pathogens. |
| Q39874089 | The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model. |
| Q39581696 | The role of mouse adenovirus type 1 early region 1A in acute and persistent infections in mice |
| Q46181439 | Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2. |
| Q37965274 | Tumor necrosis factor: an update on basic research and clinical applications |
| Q33318154 | Tumorigenicity of adenovirus-transformed cells and their sensitivity to tumor necrosis factor α and NK/LAK cell cytolysis |
| Q36361103 | Viral escape from immune recognition: multiple strategies of adenoviruses |
| Q41510729 | Viral inhibitors of apoptosis |
Search more.